Equine C-Peptide antibody and antigen (recombinant protein)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-EQU-C-Peptide-Ag01	Recombinant Equine C-Peptide protein	3090
GMP-EQU-C-Peptide-Ab01	Anti-Equine C-Peptide mouse monoclonal antibody (mAb)	1953
GMP-EQU-C-Peptide-Ab02	Anti-Equine C-Peptide mouse monoclonal antibody (mAb)	1953
GMP-EQU-C-Peptide-Ab03	Anti-Equine C-Peptide human monoclonal antibody (mAb)	1953
GMP-EQU-C-Peptide-Ab04	Anti-Equine C-Peptide human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-EQU-C-Peptide-Ag01
Product Name	Recombinant Equine C-Peptide protein
Target/Biomarker	Equine C-peptide (C-Peptide)
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Equine C-peptide antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in C-Peptide level test of animal Equine/Horse with type 1 diabetes mellitus.
Tag	His
Products description	Recombinant Equine C-Peptide protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-C-Peptide-Ab01, GMP-EQU-C-Peptide-Ab02
Product Name	Anti-Equine C-Peptide mouse monoclonal antibody (mAb)
Target/Biomarker	Equine C-peptide (C-Peptide)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Equine C-peptide antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-C-Peptide antibodies in C-Peptide level test of animal Equine/Horse with type 1 diabetes mellitus.
Tag	mFc
Products description	Anti-Equine C-Peptide mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-C-Peptide antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-EQU-C-Peptide-Ab03, GMP-EQU-C-Peptide-Ab04
Product Name	Anti-Equine C-Peptide human monoclonal antibody (mAb)
Target/Biomarker	Equine C-peptide (C-Peptide)
Expression platform	CHO
Isotypes	Human IgG1
Bioactivity validation	Recombinant Equine C-peptide antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-C-Peptide antibodies in C-Peptide level test of animal Equine/Horse with type 1 diabetes mellitus.
Tag	hFc
Products description	Anti-Equine C-Peptide human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-C-Peptide antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Equine C-Peptide, a remarkable peptide composed of 31 amino acids, is intricately intertwined with the physiological tapestry of horses. It emerges as a critical component of pancreatic function, serving as both a mirror and a marker of endogenous insulin production. C-Peptide is born during the proteolytic cleavage of proinsulin, a precursor to insulin. While insulin takes on the central role in regulating glucose homeostasis, Equine C-Peptide plays a parallel and equally crucial role, co-secreted alongside insulin by the pancreas. Equine C-Peptide follows a pulsatile release pattern into the bloodstream, a pattern that mimics the body's natural insulin secretion. This distinctive feature sets it apart from exogenously administered insulin, which delivers a continuous and uniform dose. As C-Peptide levels rise in response to elevated blood glucose levels, it serves as an invaluable indicator of the pancreas's health and its ability to produce insulin. Beyond its role as a mirror of insulin secretion, Equine C-Peptide plays an essential role in the diagnosis and management of metabolic disorders in horses. Conditions like equine metabolic syndrome (EMS) and insulin resistance are prevalent in the equine population and are associated with abnormal insulin responses. C-Peptide measurement offers vital insights into the source of this dysregulation, helping veterinarians differentiate between insulin production and receptor sensitivity issues. Equine C-Peptide is not a mere static marker; it evolves dynamically with the horse's metabolic status. This dynamic nature makes it a versatile tool in equine endocrinology. Its levels can fluctuate in response to changes in diet, exercise, and insulin sensitivity. This adaptability allows veterinarians to monitor horses over time, providing a comprehensive picture of their metabolic health.

About GDU